Orthofix Medical Inc (OFIX)
14.48
-0.62
(-4.11%)
USD |
NASDAQ |
May 21, 16:00
14.46
-0.02
(-0.10%)
After-Hours: 20:00
Orthofix Medical SG&A Expense (Quarterly): 131.69M for March 31, 2024
SG&A Expense (Quarterly) Chart
Historical SG&A Expense (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 131.69M |
December 31, 2023 | 132.28M |
September 30, 2023 | 122.08M |
June 30, 2023 | 133.43M |
March 31, 2023 | 142.60M |
December 31, 2022 | 84.79M |
September 30, 2022 | 74.78M |
June 30, 2022 | 75.73M |
March 31, 2022 | 73.46M |
December 31, 2021 | 75.36M |
September 30, 2021 | 72.41M |
June 30, 2021 | 75.67M |
March 31, 2021 | 67.23M |
December 31, 2020 | 72.21M |
September 30, 2020 | 69.47M |
June 30, 2020 | 58.53M |
March 31, 2020 | 72.18M |
December 31, 2019 | 80.42M |
September 30, 2019 | 75.90M |
June 30, 2019 | 78.80M |
March 31, 2019 | 74.17M |
December 31, 2018 | 73.42M |
September 30, 2018 | 72.17M |
June 30, 2018 | 73.49M |
March 31, 2018 | 69.69M |
Date | Value |
---|---|
December 31, 2017 | 67.02M |
September 30, 2017 | 65.56M |
June 30, 2017 | 70.88M |
March 31, 2017 | 66.81M |
December 31, 2016 | 70.29M |
September 30, 2016 | 60.99M |
June 30, 2016 | 64.59M |
March 31, 2016 | 61.83M |
December 31, 2015 | 68.45M |
September 30, 2015 | 65.48M |
June 30, 2015 | 65.45M |
March 31, 2015 | 65.85M |
December 31, 2014 | 66.04M |
September 30, 2014 | 60.32M |
June 30, 2014 | 60.23M |
March 31, 2014 | 58.45M |
December 31, 2013 | 67.17M |
September 30, 2013 | 52.01M |
June 30, 2013 | 59.72M |
March 31, 2013 | 64.08M |
December 31, 2012 | 52.48M |
September 30, 2012 | 56.87M |
June 30, 2012 | 61.37M |
March 31, 2012 | 61.70M |
December 31, 2011 | 53.08M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (Quarterly) Range, Past 5 Years
58.53M
Minimum
Jun 2020
142.60M
Maximum
Mar 2023
88.45M
Average
75.70M
Median
SG&A Expense (Quarterly) Benchmarks
Boston Scientific Corp | 1.364B |
Stryker Corp | 1.84B |
Globus Medical Inc | 248.71M |
Paragon 28 Inc | 54.22M |
ZimVie Inc | 60.33M |